Mineralys Therapeutics Inc. (MLYS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Mineralys Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$21.38
+1.18% today
Market cap
$1.9B
Overall quality
—
Kronos AI 30-day
+25.1%
8 of 8 simulated paths end higher
Mineralys Therapeutics Inc. (MLYS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.9B. It trades at $21.38, up 1.18% today. 7 analysts' average target of $47.86 implies +123.9% from today's price. Kronos AI's 30-day forecast is +25.1% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $47.86 |
| Low – high | $29.00 – $56.00 |
| Analysts | 7 |
| Upside to average | +123.9% |
Kronos AI 30-day forecast
| Expected close | $26.44 (+25.1%) |
| Likely range | +22.5% … +38.9% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.